Mechanisms of resistance to small molecule kinase inhibition in the treatment of solid tumors
- 1 October 2006
- journal article
- review article
- Published by Elsevier in Laboratory Investigation
- Vol. 86 (10) , 981-986
- https://doi.org/10.1038/labinvest.3700466
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Gastrointestinal stromal tumours: an updateHistopathology, 2005
- A Knock-In Mouse Model of Gastrointestinal Stromal Tumor Harboring Kit K641ECancer Research, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinaseProceedings of the National Academy of Sciences, 2003
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Addiction to Oncogenes--the Achilles Heal of CancerScience, 2002
- Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 studyBlood, 2002
- Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cellsNature Medicine, 1996